Key result
The abstract describes a cross-sectional study evaluating clinical and biochemical markers for metabolic syndrome in 105 women with PCOS, but reports no quantitative results.
Why the study?
To evaluate clinical and biochemical markers for metabolic syndrome in women diagnosed with polycystic ovary syndrome (PCOS).
Cross-Sectional (n=105)
No
Answers are grounded in this paper and cite their sources.
Aims and objectives: To study the clinical and biochemical markers for metabolic syndrome in women diagnosed with polycystic ovary syndrome (PCOS). Materials and methods: This is an observational (cross-sectional) study involving 105 patients of PCOS, carried out over 2 years (2018-2020) in a tertiary care hospital of Berhampur, Odisha. Weight, height, waist circumference, hip circumference, and blood pressure were measured. The W to H ratio (WHR) and body mass index (BMI) was calculated. Venous blood samples were collected after an overnight fast for glucose, serum triglycerides, and high-density lipoprotein-cholesterol. A 2-hour 75 g glucose tolerance test was done, along with fasting insulin. Homeostatic model assessment-insulin resistance (HOMA-IR) was calculated. Statistical analysis was performed by the SPSS program for Windows (v 25.0). Tests of significance were carried out.
No takes yet. Share an insight, caveat, or question.
Mishra et al. (2022) conducted a cross-sectional in Polycystic ovary syndrome (PCOS) (n=105). Polycystic ovary syndrome was evaluated on Clinical and biochemical markers for metabolic syndrome. The abstract describes a cross-sectional study evaluating clinical and biochemical markers for metabolic syndrome in 105 women with PCOS, but reports no quantitative results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: